Pharmadrama – it’s not what you do it’s the way that you do it @EFPIA @PMLiVEcom

This is a brief one. EFPIA - the European Federation for Pharmaceutical Industries and Associations - has this morning launched a manifesto for putting pharma at the heart of evonomic growth in the European Union (EU). http://www.efpia.eu/uploads/documents/EFPIA-health&growth_MANIFESTO_V11_pbp.pdf It's a comprehensive tome. With laudable recommendations and objectives on many things I would agree with it on … Continue reading Pharmadrama – it’s not what you do it’s the way that you do it @EFPIA @PMLiVEcom

More on Pfizer

Ther's a couple of good pieces in the FT (link will take you to the front page) about the Pfizer announcement yesterday. Actually, it's quite interesting reading the comments of Pfizer's CEO as reported this morning.  They give some insight into the self-critical eye that pharma is taking on how it has done things in the … Continue reading More on Pfizer

An evening of industry – how the pharma business model is changing

So it's 10pm and I'm busy here putting the final touches to the AMRC/INVOLVE report of the workshop we held in November which drew together patient views on health research regulation.  This was at the invitation of the Academy of Medical Sciences as part of their review of regulation and governance but - and all … Continue reading An evening of industry – how the pharma business model is changing

Time to open up about industry

Every so often a story and resulting furore crops up in the media about charities, patient groups and their closeneness to industry and, in particular, pharmaceutical companies.   Journalists and the public will quite rightly ask: is it in the public interest?  I can well remember my first encounter with big pharma in my early days … Continue reading Time to open up about industry